Investigator-initiated trials (IITs) support independent investigators and academic sponsors conducting clinical and non-clinical research to advance knowledge about Lundbeck compounds and improve patients’ lives.
Investigator Initiated Studies (IIS) supports scientists and clinical researchers pursuing independent clinical, observational, and outcomes research to explore questions or develop new treatment concepts.
Investigator-Initiated Research (IIR) supports independent investigators with funding, study drug, or data and samples for research addressing unmet patient needs or important scientific questions.
Investigator Initiated Studies (IIS) Program supports independent investigators and institutions studying Eisai products and compounds to address medical or scientific questions in neurology and oncology.
Investigator Initiated Studies (IIS) supports investigators and research sponsors conducting clinical studies to deepen understanding of Genentech medicines, improve patient care, and inspire disease research.
Investigator-Initiated Studies supports independent researchers through Sarepta Therapeutics funding or study materials to answer medical and scientific questions in rare neuromuscular diseases.